Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
View Menu
Sensyne Health | Investors

Shareholder Information

Keeping our shareholders and potential investors informed about recent news, share price, and other relevant information

Investor enquiries:

AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.

Please see here for our Statement of Compliance with the Quoted Companies Alliance Corporate Governance Code.

Please see here for the Chairman’s Statement.

Company information

Registered Office

John Eccles House, Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GP

Sensyne Health plc is incorporated in England and Wales under registered number 11425451. Its main country of operation is the United Kingdom.

Please see here for a description of Business
Please see here for details on the Board and Committees.
Please see here for information on Corporate Governance.


Company Secretary

Laura Hillier

JOINT Broker AND Nominated Advisor  

Peel Hunt LLP, Moor House, 120 London Wall, London EC2Y 5ET

JOINT Broker

Liberum, 25 Ropemaker St, London EC2Y 9LY

Legal Advisers to the Company

Allen & Overy LLP, One Bishops Square, London E1 6AD
Covington & Burling LLP, 265 Strand, London WC2R 1BH


Grant Thornton LLP, 30 Finsbury Square, London EC2A 1AG


Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA

Public Relations

Consilium Strategic Communications, 41 Lothbury, London EC2R 7HG

Securities information

The Company’s ordinary shares are admitted to trading on AIM. There are no other exchanges or trading platforms on which the Company has applied or agreed to have any of its securities (including its AIM securities) admitted or traded.

There are no restrictions on the transfer of the Company’s ordinary shares.

The Company’s issued share capital consists of 164,799,139 ordinary shares of 10 pence each and the following interests of shareholders in excess of 3 per cent have been notified to the Company.

A total of 23.8% of the issued share capital is not in public hands and there are no shares held in treasury.

The Company is subject to the UK City Code on Takeovers and Mergers.

Regulatory News

Please see here for information on Regulatory News


Admission Document
Articles of Association
The Audit and Risk Committee's terms of reference
The Remuneration Committee's terms of reference
The Nomination Committee's terms of reference
Matters Reserved for the Board

The above information was last updated on 28/03/2022